CLINICAL VALUE OF BLOOD BIOMARKERS IN PATIENTS WITH CHRONIC HEART FAILURE

CLINICAL VALUE OF BLOOD BIOMARKERS IN PATIENTS WITH CHRONIC HEART FAILURE

Biomarkers (various laboratory biochemical markers), such as natriuretic peptides (NP), soluble ST2 receptor, copeptin, galectin-3, are widely studied in patients with chronic heart failure (CHF). The European Society of Cardiology recommends the determination of blood NP level in suspicion of HF an...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. M. Aliyeva, E. V. Reznik, E. T. Hasanova, I. V. Zhbanov, I. G. Nikitin
Format:	Article
Language:	Russian
Published:	SINAPS LLC 2018-10-01
Series:	Архивъ внутренней медицины
Subjects:	chronic heart failure biomarkers biochemical blood test myocardial infarction natriuretic peptides brain natriuretic peptide nt-probnp soluble st2 receptor copeptin galectin-3 prognosis risk stratification diagnosis treatment management
Online Access:	https://www.medarhive.ru/jour/article/view/835
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of the Myocardial Stress Biomarker NT-proBNP in Real Clinical Practice
by: I. A. Kozlov, et al.
Published: (2023-02-01)

Analysis of distant cardiovascular events depending on the biomarker profile in patients with myocardial infarction
by: A. F. Khamitova, et al.
Published: (2019-04-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

Effect of six weeks low intensity interval training on expression of atrial and brain natriuretic peptide genes following myocardial infarction in rat
by: mehran ghahremani, et al.
Published: (2019-07-01)

N-terminal Pro-B-Type Natriuretic Peptide is a Myocardial Biomarker in Pulmonary Sepsis and Septic Shock
by: I. N. Tyurin, et al.
Published: (2022-10-01)

A Clinical Study of the N-Terminal pro-Brain Natriuretic Peptide in Myocardial Injury after Neonatal Asphyxia
by: Rui Zhu, et al.
Published: (2016-04-01)

Effects of Acute Exercise Bouts on Cardiovascular Biomarkers in Runners with Exercise-Induced Hypertension
by: Young-Joo Kim, et al.
Published: (2025-06-01)

Pro-C-Type Natriuretic Peptide in Women With Angina Pectoris and No Obstructive Coronary Artery Disease
by: Peter D. Mark, MD, PhD, et al.
Published: (2025-07-01)

Increased B-type Natriuretic Peptide (NT-proBNP) Level as a Risk Factor in Cardiosurgical Patients
by: I. A. Kozlov, et al.
Published: (2010-02-01)

Biochemical and echocardiographic markers for the early detection of cardiotoxicity under monoclonal antibodies therapy
by: Ionela-Emilia Popovici, et al.
Published: (2021-04-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Comparison of the prognostic potential of biomechanic stress markers - circulating stromelysin-1, matrix metalloprteinase-9 and N-terminal fragment of brain natriuretic peptide in patients with acute Q-wave myocardial infarction. Results of cohort study
by: T. Samura
Published: (2012-04-01)

Prognostic significance of the biomarker NT-proBNP in the surgical treatment of aortic stenosis (pilot study)
by: I. A. Kozlov, et al.
Published: (2023-06-01)

Natriuretski peptidi u kliničkoj praksi
by: Matunović Radomir, et al.
Published: (2005-01-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

ON THE GENETIC REGULATION OF BRAIN NATRIURETIC PEPTIDE LEVEL IN PLASMA OF MEN WITH ESSENTIAL HYPERTENSION
by: I. P. Pashkovа, et al.
Published: (2017-03-01)

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex
by: David Bobrowski, MD, et al.
Published: (2025-08-01)

Informativeness of various predictors of perioperative cardiovascular complications in non-cardiac surgery
by: D. A. Sokolov, et al.
Published: (2023-05-01)

Brain natriuretic peptide: diagnostic and prognostic value in chronic heart failure (a literature review)
by: O. O. Sakovych, et al.
Published: (2024-05-01)

Pericardial Fluid Biomarkers as Early Predictors for Postoperative Atrial Fibrillation—A Systematic Review
by: Florin Mitu, et al.
Published: (2025-02-01)

Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19
by: V. I. Podzolkov, et al.
Published: (2023-01-01)

GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01)

Effect of galectin-3 and brain natriuretic peptide levels on echocardiographic parameters of left heart chamber following coronary artery bypass grafting
by: Yulia A. Styazhkina, et al.
Published: (2024-12-01)

NATRIURETIC PEPTIDE AND HIS PROGENITORS AS PREDICTORS OF PROGRESSIVE POSTOPERATIVE LEFT VENTRICLE REMODELING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: S. S. Gutor, et al.
Published: (2013-12-01)

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01)

DIAGNOSTIC SIGNIFICANCE OF NOVEL MARKERS FOR ASSESSMENT OF MYOCARDIUM CONDITION IN OBSTRUCTIVE DIFFUSE-GENERALIZED FORM OF HYPERTROPHIC CARDIOMYOPATHY
by: Yu. V. Frolova, et al.
Published: (2016-11-01)

B-type natriuretic peptide informativeness in myocardial revascularization with cardio-pulmonary bypass
by: I. A. Kozlov, et al.
Published: (2024-08-01)

Assessment of glomerular and tubulointerstitial apparatus state depending on the level of the natriuretic peptide in hypertension patients
by: A. I. Chernyavina
Published: (2020-04-01)

Post-Discharge Cardiovascular Complications in Noncardiac Surgery: Incidence and Prediction
by: D. A. Sokolov, et al.
Published: (2024-12-01)

Risk prediction in acute coronary syndrome depending on the types of myocard revascularization
by: R. V. Denina
Published: (2016-12-01)

The relationship of gene polymorphism with the heart failure risk in patients with hypertension and high adherence to treatment
by: N. A. Koziolova, et al.
Published: (2020-04-01)

Efficiency of meldonium application in complex treatment of patients with chronic heart failure decompensation
by: A. S. Sycheva, et al.
Published: (2021-06-01)

Predictive value of brain natriuretic peptide for cardiovascular risk assessment in non-cardiac surgery
by: O. N. Dzhioeva, et al.
Published: (2020-11-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Predictive markers of atrial fibrillation in patients after acute ST-elevated myocardial infarction (the results of observational program “FAKEL”)
by: I. A. Zolotovskaya, et al.
Published: (2018-10-01)

The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01)

GALECTIN-3 AS A MARKER OF MYOCARDIAL FUNCTION IN MEN AGED 40-60 YEARS WITHOUT CARDIOVASCULAR PATHOLOGY, CARRIERS OF POLYMORPHIC GENES AT1R
by: V.O. Ruzhanska, et al.
Published: (2018-03-01)

Navigating the challenges of NT-proBNP result disclosure in clinical research
by: Denise A. Kent, et al.
Published: (2025-01-01)

Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
by: B. B. Samura
Published: (2017-12-01)

Perioperative Myocardial Damage and Heart Failure in Noncardiac Surgery. Part 1. Etiopathogenesis and Prognosis of Perioperative Cardiac Complications (Review)
by: I. A. Kozlov, et al.
Published: (2019-04-01)